Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Inamed augments PMA filing

This article was originally published in The Gray Sheet

Executive Summary

Supplemental data for firm's silicone gel-filled breast implants have been submitted to FDA, company announces Aug. 19. The addition responds to a January FDA non-approvable letter (1"The Gray Sheet" Jan. 12, 2004, p. 3). Inamed also has filed seven-year follow-up data on saline implants, required as a condition of May 2000 PMA approval, according to an Aug. 12 release (2"The Gray Sheet" May 15, 2000, p. 15). The data found a 9.8% deflation rate for the 876-patient augmentation cohort and 12.4% deflation for the 194-patient reconstruction cohort...

You may also be interested in...



Breast Implant PMA Timeframes Tested By Inamed “Not-Approvable” Letter

Firms seeking premarket approval for silicone breast implants should conduct tests designed to more closely predict rupture and gel bleed under real-world conditions, according to new FDA draft guidelines

Saline-Filled Breast Implant Labels Note 13-40% Re-operation Rate At 3 Years

Informed consent labeling for saline-filled breast implants notes that 13-40% of women who receive the implants require some form of additional surgical treatment within three years.

COVID-19 Lockdown: India Pharma Manufacturing Limps Along Amid Challenges

Pharma manufacturing is operating well below normal levels in India, disrupted by labor absenteeism and supply chain issues amid the ongoing lock-down in the country, though the government is actively engaged in addressing bottlenecks. A speedy recovery is vital not just for domestic supplies.

UsernamePublicRestriction

Register

MT020768

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel